Grace & White’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
Grace & White's NWBO Position: Q2 2023 in Review
Grace & White sold out of Northwest Biotherapeutics (NWBO) in Q2 2023, closing a stake of 14,705 shares — an estimated $9.19K sold.
Grace & White first reported a position in NWBO in Q4 2020 and held it in 10 quarters. The position peaked at $38K in Q1 2021. 11 funds tracked by Wall St. Rank hold NWBO as of Q2 2023.
- Grace & White reported no remaining Northwest Biotherapeutics position as of Q2 2023 after selling out during the quarter.
- Grace & White sold 14,705 Northwest Biotherapeutics shares in Q2 2023, an estimated $9.19K.
- Grace & White first reported a position in Northwest Biotherapeutics in Q4 2020 and held it in 10 quarters.
- Grace & White's Northwest Biotherapeutics position peaked at $38K in Q1 2021.
- 11 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q2 2023.
Based on Grace & White's 13F filing for Q2 2023, filed 26 Jul 2023.